BOSTON (TheStreet) -- I've put together an updated calendar of meaningful clinical trials with results expected through the end of the current year. The biotech and drug companies included here are listed in alphabetical order.
Unlike U.S. Food and Drug Administration drug approvals, which are more precisely timed, the release dates for data from clinical trials is a bit fuzzier, so the timelines here are culled from company guidance when possible.
Successful biotech traders and investors understand the importance of staying one step ahead of stock-moving catalysts in the biotech sector. Use this clinical trial list as a companion to my recently published FDA drug approval calendar.
This list was compiled using company reports and the BioMedTracker service from Sagient Research, a subscription-based tool for keeping track of biotech and drug catalysts.Read on for the list.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV